Oncology & Cancer

New drug candidate developed against NF1 cancers tumours

Bath researchers have worked with colleagues from the University of Michigan to design a promising new anticancer drug candidate. This new drug would be used in the fight against Neurofibromatosis (NF1). The work, from Professor ...

Oncology & Cancer

Drug candidate kills cancer cells through overstimulation

A drug candidate that overstimulates proteins crucial for tumor growth shows promise as a new strategy to treat a wide range of cancers. The demands of rapid cell division put a strain on cancer cells, and the approach works ...

Oncology & Cancer

First made-in-Singapore cancer drug enters clinical testing

A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the lives of cancer patients in Singapore, and worldwide. ...

Alzheimer's disease & dementia

Past failures pave way for promising new Alzheimer's treatments

Since 2002, close to 300 drug candidates to treat Alzheimer's have run into clinical dead ends. But now, having learned from those failures, researchers are testing—and retesting—a batch of the most promising compounds ...

Diseases, Conditions, Syndromes

Experimental Ebola treatment boosts survival in mice

The number of new Ebola cases is tapering off, but the search for new treatments continues. Now, one research team has found potential drug candidates that successfully treated up to 90 percent of mice exposed to the Ebola ...

page 10 from 20